Abstract Heat-shock protein 60 (Hsp60) is ubiquitous and highly conserved being present in eukaryotes and prokaryotes, including pathogens. This chaperonin, although typically a mitochondrial protein, can also be found in other intracellular sites, extracellularly, and in circulation. Thus, it can signal the immune system and participate in the development of inflammation and immune reactions. Both phenomena can be elicited by human and foreign Hsp60 (e.g., bacterial GroEL), when released into the blood by infectious agents. Consequently, all these Hsp60 proteins become part of a complex autoimmune response characterized by multiple cross reactions because of their structural similarities. In this study, we demonstrate that Hsp60 proteins from humans and two common pathogens, Chlamydia trachomatis and Chlamydia pneumoniae, share various sequence segments of potentially highly immunogenic epitopes with acetylcholine receptor a1 subunit (AChRa1). The structural data indicate that AChRa1 antibodies, implicated in the pathogenesis of myasthenia gravis, could very well be elicited and/or maintained by self-and/or bacterial Hsp60.
Introduction
Unfolded or misfolded proteins may interfere with the machinery of the cell. For this reason, prokaryotic and eukaryotic cells have evolved special macromolecular ''chaperone'' complexes that capture and refold partially folded proteins (Ellis 2007) . First observed in cells exposed to high temperatures, heat shock proteins (Hsps) have been identified as chaperones and found to increase in response to a number of cell stress stimuli (Haak and Kregel 2008) . Chaperonins, a subset of chaperones, are classified in two groups: those belonging to Group I are found in bacteria (GroEL) and eukaryotic organelles (mitochondrial Hsp60, often called also Cpn60), while Group II chaperonins are present in archaea (thermosome subunits) and eukaryotic cytoplasm (CCT) (Macario et al. 1999) .
The mitochondrial Hsp60 (hereinafter ''Hsp60'') is one of the most conserved human molecular chaperones and is also present in several kinds of pathogens (Sakamoto and Ohkuma 2010) . In eukaryotic cells, this protein is classically considered an intracellular chaperone, working together with its co-chaperonin Hsp10 to assist in the folding of other mitochondrial proteins (Horwich et al. 2007; Lund 2009 ). Hsp60 has also been found in extra-mitochondrial sites, as well as in the extracellular environment and bloodstream, and thus can stimulate the innate and the adaptive immune systems (Habich and Burkart 2007; Henderson 2010; Quintana and Cohen 2011) . Hsp60 activates macrophages and dendritic cells, stimulates production of pro-inflammatory molecules, and leads to activation of Hsp60-specific T cell responses. Moreover, both microbial and human Hsp60 are strongly antigenic and can trigger the production of relatively large amounts of antibodies. Not surprisingly, autoantibodies to self-Hsp60 are detected in several autoimmune and inflammatory diseases (Quintana and Cohen 2011).
Myasthenia gravis (MG) is a neuromuscular disorder caused by a T-cell-dependent and B-cell-mediated autoimmune response to the muscle-type nicotinic acetylcholine receptor (AChR), which compromises neuromuscular transmission (Moiola et al. 1998; Hohlfeld and Wekerle 2008; Le Panse et al. 2008; Helgeland et al. 2011 (Arias 2000) . The MIR is a conformation-dependent region with immunogenic relevance for its prominent location, acting as a antigenic epitope in MG (Brejc et al. 2001) . The presence of this region might allow native AChRs to be effective in binding to receptor immunoglobulins on the surface of pre-B lymphocytes (Lindstrom et al. 2008) . Several experiments, carried out by creating chimeras of human a1 subunits, have demonstrated that half or more of the autoantibodies to AChR in MG are directed against MIR, thus confirming its prominent pathogenetic role (Lindstrom et al. 2008; Luo et al. 2009 ). Moreover, the presence of the a1 MIR sequence in chimeric AChR greatly influences its sensitivity to activation by Ach (Luo et al. 2009 ). In a1 subunits, conformation maturation of the MIR and the ACh-binding site occurs simultaneously before assembly, revealing the structural and functional significance of the former (Brejc et al. 2001; Luo et al. 2009 ). The question is: How do anti-AChR antibodies arise? We previously reported several highly homologous amino-acid sequences when comparing human and Chlamydial Hsp60 with various subunits of human AChRs . In the present study, we extended our search to all the homologous epitopes that result from the comparison between the amino-acid sequences of AChRa1 and Homo sapiens Hsp60 (Hs-Hsp60), or Chlamydia trachomatis GroEL (Ct-Hsp60), or Chlamydia pneumoniae GroEL (Cp-Hsp60). We also mapped these epitopes within the three-dimensional structure of the AChRa1 molecule with particular attention to the MIR and the ACh-binding site. Our results support the hypothesis of cross-reactivity between human and Chlamydial Hsp60s with AChR, which would lead to a humoral antiHsp60 immune response that would also react with AChR and, thus, contribute to the pathogenesis of MG.
Methods
The amino-acid sequences of AChRa1, Hs-Hsp60, Ct-Hsp60, and Cp-Hsp60 were obtained from the PubMed website (http://www.ncbi.nlm.nih.gov/genbank/) using the access numbers Y00762, NM002156, AJ783840, and AAP98858, respectively. Sequence comparisons were performed using the SIM software (http://expasy.org/tools/ sim-prot.html), and a three-dimensional model of AChRa1 monomer was obtained using the 3D-JIGSAW software 
Results and Discussion
The alignment of the amino-acid sequences of Hs-Hsp60 and AChRa1 revealed four epitopes with a percentage of similarity (identities plus conservative substitutions) comprised between 33.3 and 53.8 (Table 1) . Likewise, the alignment of the amino-acid sequences of Ct-Hsp60 and AChRa1 showed four homologous epitopes with a similarity percentage comprised between 27.6 and 62.5. The comparison of the amino-acid sequences of Cp-Hsp60 and AChRa1 revealed 10 homologous epitopes with a percentage of similarity comprised between 18.2 and 55.6. Interestingly, these epitopes were mostly localized around or inside either the MIR or the ACh-binding site of AChRa1 (Fig. 1) . Hsp60 of pathogenic eukaryotes and prokaryotes share numerous highly homologous (if not identical) amino-acid sequences distributed along the entire Hsp60 sequence with the potential of eliciting, by molecular mimicry, the production of cross-reactive antibodies after infection with these pathogens ). For example, GroEL of Chlamydiaceae share several epitopes with Hs-Hsp60 (Campanella et al. 2009 ). Thus, chlamydial Hsp60 represents a common dominant bacterial antigen, and immune responses to this pathogen are characterized by the production of antibodies to it ). As a consequence, the potential cross-reactivity between the microbial chaperonin and its human counterpart may predispose to autoimmunity. Recurrent infections and the ensuing prolonged antibody response may cause the exacerbation of an underlying autoimmune disease. In addition, enhanced expression of Hs-Hsp60 under stress conditions can also unveil previously silent antigenic determinants that can initiate and perpetuate autoimmune reactivity (Quintana and Cohen 2011) .
There is extensive information about the association between autoantibodies to Hs-Hsp60 and the development of various autoimmune and inflammatory diseases, including type 1 diabetes, rheumatoid arthritis, multiple sclerosis, lupus, atherosclerosis, Behçet's disease, and inflammatory bowel disease (Quintana and Cohen 2011) . However, very little is known about the humoral immune response to Hsp60 in MG, while the clinical association between chlamydial infection and MG has not been examined before. By contrast, the involvement of molecular mimicry for antigens from other bacterial infections (like M. pnuemoniae and S. thyphimurium) has been already postulated (Deitiker et al. 2000) .
In this study, we found several potentially immunogenic epitopes that are located in the extracellular region of AChRa1, around and inside the MIR or the ACh-binding site, that are also present in Hsp60. These results strongly support the notion that human and bacterial Hsp60 might play a key role in the development of an autoimmune response against AChRa1. Thus, AChRa1 would become target for antibodies elicited by self-or foreign Hsp60, for example, during a chlamydial infection. If so, myasthenia gravis should also be considered a chaperonopathy , in which normal chaperones play a role in pathogenesis rather than the reverse, and therapeutic efforts should include blocking the chaperonins or their antibodies, or both.
